Abingdon Health
plc
("Abingdon Health" or "the Company")
Launch of OEM self-tests in
Boots
Boots to sell its first own
brand self-tests in stores and online across the UK provided by
Abingdon Health and Crest Medical partnership.
York, U.K. 20th March
2024: Abingdon Health plc (AIM:
ABDX), a leading international lateral flow Contract Development
and Manufacturing Organisation (CDMO), announces the launch of
Boots' own-brand, rapid self-tests across the UK and online in
partnership with Crest Medical.
In a significant step forward in
strengthening its position in the consumer lateral flow self-test
market, Abingdon Health is launching the first two products - Iron
and Vitamin D deficiency self-tests - in this Boots own-brand
range, with the self-tests being made available in stores and
online at Boots.com from Spring 2024. These products will sit
within the Boots family of branded products which will increase
consumer confidence in the continued adoption of at-home
testing.
As a CRO/CDMO of lateral flow tests,
Abingdon Health is uniquely positioned to offer Original Equipment
Manufacturer (OEM) self-tests under its own brand families to
partners throughout the UK and Europe as a value-add Private Label
Supplier (PLS). The global lateral flow assay market size is
expected to reach USD $23 billion by 20271 and with
consumer adoption of self-tests on the rise (US $7.89 billion in
2023)2, this has coincided with retailers looking to
offer these products under their own brands to improve their
consumer offering.
Chris Yates, CEO of Abingdon Health plc,
commented: "We are delighted to
announce the launch of the Boots own-brand Iron and Vitamin D
deficiency self-tests in conjunction with our partner Crest
Medical. As lateral flow experts we're proud to offer a
comprehensive private label service to retailers covering a broad
range of self-tests, including innovative exclusive products from
Abingdon's CDMO customers. We take immense pride in the quality of
our service and ensure a seamless supply of innovative lateral flow
self-tests to ensure our partners requirements are
met."
Matthew Courtney, CEO of Crest Medical Ltd,
commented: "Diagnostic tests are
another great addition to the Crest Medical portfolio as we look to
expand further and deepen our partnership with Boots. Abingdon
Health are at the forefront of this expansion and we are thrilled
to be partnering with a company who are leaders in lateral flow
diagnostics."
Sources:
1.
1.
Lateral Flow Assays Market worth $22.6 billion | MarketsandMarkets
| ABNewswire
2. Self-testing
Market Share, Growth, Demand, Forecast to 2033
(futuremarketinsights.com)
Enquiries
|
Abingdon Health plc
|
www.abingdonhealth.com/investors/
|
|
Chris Yates, Chief Executive Officer
|
|
|
Chris Hand, Non-Executive Chairman
|
|
|
|
|
|
Singer Capital Markets (Sole Broker and Nominated
Adviser)
|
Tel: +44
(0)20 7496 3000
|
|
Peter Steel, Alex Bond, Jalini
Kalaravy (Corporate Finance)
|
|
|
Tom Salvesen (Corporate
Broking)
|
|
|
|
|
About Abingdon Health plc
Abingdon Health is a leading
lateral flow contract development and manufacturing organisation
("CDMO") offering its services to an international customer base
across industry sectors that include clinical, animal health, plant
health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to
routine and large-scale manufacturing; from "idea to commercial
success."
The Company's CDMO division offers
product development, regulatory support, technology transfer and
manufacturing services for customers looking to develop new assays
or transfer existing laboratory-based assays to a lateral flow
format. Abingdon Health aims to support the increase in
need for rapid results across many industries and locations and
produces lateral flow tests in areas such as infectious disease,
clinical testing including companion diagnostics, animal health and
environmental testing. Faster access to results allows for rapid
decision making, targeted intervention and can support better
outcomes.
Abingdon Health's Abingdon Simply
Test range of self-tests is an ecommerce platform that offers a
range of self-tests to empowers consumers to manage their own
health and wellbeing. The Abingdon Simply
Test ecommerce site offers
consumers a range of information to support them in making informed
decisions on the tests available. In addition, the site provides
Abingdon's contract services customers with a potential route to
market for self-tests. The Abingdon Simply Test range is also sold
through international distributors and through other channels in
the UK and Ireland such as pharmacy chains.
Founded in 2008, Abingdon
Health is headquartered in York, England.
For more information
visit: www.abingdonhealth.com